Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Gemcitabine Followed by Radiation for Uterine MMMT
NCT00476086Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Aug 2006
- Primary completion
- Mar 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, gemcitabine in uterine carcinosarcoma (UCS), sponsored by Dana-Farber Cancer Institute. Started Aug 2006; status: completed.
02
Drugs
oxaliplatingemcitabine
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT00476086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476086.